Login Register Cart 0
Generic placeholder image

Current Radiopharmaceuticals

Editor-in-Chief

ISSN (Print): 1874-4710
ISSN (Online): 1874-4729

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis

Author(s): Assuero Giorgetti*, Dario Genovesi and Michele Emdin

Volume 14, Issue 3, 2021

Published on: 22 April, 2020

Page: [259 - 272] Pages: 14

DOI: 10.2174/1874471013666200422102406

Price: $65

Abstract

Endocarditis, myocarditis and pericarditis are a heterogeneous group of phenotypic syndromes where the culprit area of inflammation is the heart. Inflammation may be determined by an infective agent, toxins, drugs or an activated immune system. Clinical manifestations can be subtle and diagnosis remains a challenge for cardiologists, requiring high level of suspicion and advanced multimodal cardiac imaging to avoid life-threatening consequences. The purpose of this review is to report the recent advances of PET/CT imaging with 18FDG in helping the management of patients affected by inflammatory heart disease. Two independent reviewers searched in PubMed articles published before or in June 2019 and final decisions on the inclusion of references were done in consensus with a third reviewer. At the end of the selection process 23/206 articles on “cardiac inflammation”; 26/235 articles on “endocarditis”, “prosthetic heart valve”, “pacemaker”, “implantable cardiac device”; 7/103 articles on “myocarditis”; 13/330 articles on sarcoidosis” and 2/19 articles on “pericarditis” were included. Compared with the conventional methods, molecular imaging has the advantage to non-invasively and directly trace the inflammatory process, and to identify earlier the presence and the extent of intra-cardiac and extra-cardiac involvement, to enable quantification of disease activity, guide therapeutic interventions, and monitor treatment success.

Keywords: PET/CT, inflammatory, molecular imaging, cardiologists, myocarditis, echocardiography.

« Previous Next »
Graphical Abstract

[1]
Libby, P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr., 2006, 83(2), 456S-460S.
[http://dx.doi.org/10.1093/ajcn/83.2.456S] [PMID: 16470012]
[2]
Kubota, R.; Kubota, K.; Yamada, S.; Tada, M.; Ido, T.; Tamahashi, N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorode- oxyglucose uptake. J. Nucl. Med., 1994, 35(1), 104-112.
[3]
Yamada, S.; Kubota, K.; Kubota, R.; Ido, T.; Tamahashi, N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J. Nucl. Med., 1995, 36(7), 1301-1306.
[PMID: 7790960]
[4]
Kaim, A.H.; Weber, B.; Kurrer, M.O.; Gottschalk, J.; Von Schulthess, G.K.; Buck, A. Autoradiographic quantification of 18F-FDG uptake in experimental soft-tissue abscesses in rats. Radiology, 2002, 223(2), 446-451.
[http://dx.doi.org/10.1148/radiol.2232010914] [PMID: 11997551]
[5]
Deichen, J.T.; Prante, O.; Gack, M.; Schmiedehausen, K.; Kuwert, T. Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur. J. Nucl. Med. Mol. Imaging, 2003, 30(2), 267-273.
[http://dx.doi.org/10.1007/s00259-002-1018-8] [PMID: 12552345]
[6]
Iozzo, P.; Geisler, F.; Oikonen, V.; Mäki, M.; Takala, T.; Solin, O.; Ferrannini, E.; Knuuti, J.; Nuutila, P. Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study. J. Nucl. Med., 2003, 44(5), 682-689.
[PMID: 12732668]
[7]
Garbarino, S.; Vivaldi, V.; Delbary, F.; Caviglia, G.; Piana, M.; Marini, C.; Capitanio, S.; Calamia, I.; Buschiazzo, A.; Sambuceti, G. A new compartmental method for the analysis of liver FDG kinetics in small animal models. EJNMMI Res., 2015, 5(1), 107.
[http://dx.doi.org/10.1186/s13550-015-0107-1] [PMID: 26077542]
[8]
Houshmand, S.; Salavati, A.; Segtnan, E.A.; Grupe, P.; Høilund-Carlsen, P.F.; Alavi, A. Dual-time-point Imaging and Delayed-time-point Fluorodeoxyglucose-PET/Computed Tomography Imaging in Various Clinical Settings. PET Clin., 2016, 11(1), 65-84.
[http://dx.doi.org/10.1016/j.cpet.2015.07.003] [PMID: 26590445]
[9]
Fallavollita, J.A.; Luisi, A.J., Jr; Yun, E.; deKemp, R.A.; Canty, J.M., Jr An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy. J. Nucl. Cardiol., 2010, 17(4), 637-645.
[http://dx.doi.org/10.1007/s12350-010-9228-0] [PMID: 20387134]
[10]
Ambrosini, V.; Zompatori, M.; Fasano, L.; Nanni, C.; Nava, S.; Rubello, D.; Fanti, S. (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study. Clin. Nucl. Med., 2013, 38(4), e171-e177.
[http://dx.doi.org/10.1097/RLU.0b013e31827a27df] [PMID: 23429384]
[11]
Harisankar, C.N.; Mittal, B.R.; Agrawal, K.L.; Abrar, M.L.; Bhattacharya, A. Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake. J. Nucl. Cardiol., 2011, 18(5), 926-936.
[http://dx.doi.org/10.1007/s12350-011-9422-8] [PMID: 21732228]
[12]
Manabe, O.; Yoshinaga, K.; Ohira, H.; Masuda, A.; Sato, T.; Tsujino, I.; Yamada, A.; Oyama-Manabe, N.; Hirata, K.; Nishimura, M.; Tamaki, N. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J. Nucl. Cardiol., 2016, 23(2), 244-252.
[http://dx.doi.org/10.1007/s12350-015-0226-0] [PMID: 26243179]
[13]
Osborne, M.T.; Hulten, E.A.; Murthy, V.L.; Skali, H.; Taqueti, V.R.; Dorbala, S.; DiCarli, M.F.; Blankstein, R. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J. Nucl. Cardiol., 2017, 24(1), 86-99.
[http://dx.doi.org/10.1007/s12350-016-0502-7] [PMID: 27277502]
[14]
Wollenweber, T.; Roentgen, P.; Schäfer, A.; Schatka, I.; Zwadlo, C.; Brunkhorst, T.; Berding, G.; Bauersachs, J.; Bengel, F.M. Characterizing the inflammatory tissue response to acute myocardial infarction by clinical multimodality noninvasive imaging. Circ. Cardiovasc. Imaging, 2014, 7, 811-818.
[http://dx.doi.org/10.1161/CIRCIMAGING.114.001689]
[15]
Scholtens, A.M.; Verberne, H.J.; Budde, R.P.; Lam, M.G. Additional heparin pre-administration improves cardiac glucose metabolism suppression over low carbohydrate diet alone in 18F-FDG-PET imaging. J. Nucl. Med., 2016, 57(4), 568-573.
[http://dx.doi.org/10.2967/jnumed.115.166884] [PMID: 26659348]
[16]
Giorgetti, A.; Marras, G.; Genovesi, D.; Filidei, E.; Bottoni, A.; Mangione, M.; Emdin, M.; Marzullo, P. Effect of prolonged fasting and low molecular weight heparin or warfarin therapies on 2-deoxy-2-[18F]-fluoro-D-glucose PET cardiac uptake. J. Nucl. Cardiol., 2018, 25(4), 1364-1371.
[http://dx.doi.org/10.1007/s12350-017-0800-8] [PMID: 28160263]
[17]
Raplinger, K.; Chandler, K.; Hunt, C.; Jackson, G.; Peller, P. Effect of steroid use during chemotherapy on SUV levels in PET/CT. J. Nucl. Med., 2012, 53, 2718.
[18]
Jamar, F.; Buscombe, J.; Chiti, A.; Christian, P.E.; Delbeke, D.; Donohoe, K.J.; Israel, O.; Martin-Comin, J.; Signore, A. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J. Nucl. Med., 2013, 54(4), 647-658.
[http://dx.doi.org/10.2967/jnumed.112.112524] [PMID: 23359660]
[19]
Mikail, N.; Benali, K.; Ou, P.; Slama, J.; Hyafil, F.; Le Guludec, D.; Rouzet, F. Detection of mycotic aneurysms of lower limbs by whole-body (18)F-FDG-PET. JACC Cardiovasc. Imaging, 2015, 8(7), 859-862.
[http://dx.doi.org/10.1016/j.jcmg.2014.10.019] [PMID: 26183557]
[20]
Morooka, M.; Kubota, K.; Kadowaki, H.; Ito, K.; Okazaki, O.; Kashida, M.; Mitsumoto, T.; Iwata, R.; Ohtomo, K.; Hiroe, M. 11C-methionine PET of acute myocardial infarction. J. Nucl. Med., 2009, 50(8), 1283-1287.
[http://dx.doi.org/10.2967/jnumed.108.061341] [PMID: 19617334]
[21]
Maya, Y.; Werner, R.A.; Schütz, C.; Wakabayashi, H.; Samnick, S.; Lapa, C.; Zechmeister, C.; Jahns, R.; Jahns, V.; Higuchi, T. 11C-methionine PET of myocardial inflammation in a rat model of experimental autoimmune myocarditis. J. Nucl. Med., 2016, 57(12), 1985-1990.
[http://dx.doi.org/10.2967/jnumed.116.174045] [PMID: 27390159]
[22]
Lapa, C.; Reiter, T.; Li, X.; Werner, R.A.; Samnick, S.; Jahns, R.; Buck, A.K.; Ertl, G.; Bauer, W.R. Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI. Int. J. Cardiol., 2015, 194, 44-49.
[http://dx.doi.org/10.1016/j.ijcard.2015.05.073] [PMID: 26005805]
[23]
Pinkston, K.L.; Gao, P.; Singh, K.V.; Azhdarinia, A.; Murray, B.E.; Sevick-Muraca, E.M.; Harvey, B.R. Antibody guided molecular imaging of infective endocarditis. Methods Mol. Biol., 2017, 1535, 229-241.
[http://dx.doi.org/10.1007/978-1-4939-6673-8_15] [PMID: 27914083]
[24]
Millar, B.C.; de Camargo, R.A.; Alavi, A.; Moore, J.E. PET/Computed Tomography Evaluation of Infection of the Heart. PET Clin., 2019, 14(2), 251-269.
[http://dx.doi.org/10.1016/j.cpet.2018.12.006] [PMID: 30826023]
[25]
Wallace, S.M.; Walton, B.I.; Kharbanda, R.K.; Hardy, R.; Wilson, A.P.; Swanton, R.H. Mortality from infective endocarditis: clinical predictors of outcome. Heart, 2002, 88(1), 53-60.
[http://dx.doi.org/10.1136/heart.88.1.53] [PMID: 12067945]
[26]
Wang, A.; Athan, E.; Pappas, P.A.; Fowler, V.G., Jr; Olaison, L.; Paré, C.; Almirante, B.; Muñoz, P.; Rizzi, M.; Naber, C.; Logar, M.; Tattevin, P.; Iarussi, D.L.; Selton-Suty, C.; Jones, S.B.; Casabé, J.; Morris, A.; Corey, G.R.; Cabell, C.H. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA, 2007, 297(12), 1354-1361.
[http://dx.doi.org/10.1001/jama.297.12.1354] [PMID: 17392239]
[27]
Amat-Santos, I.J.; Messika-Zeitoun, D.; Eltchaninoff, H.; Kapadia, S.; Lerakis, S.; Cheema, A.N.; Gutiérrez-Ibanes, E.; Munoz-Garcia, A.J.; Pan, M.; Webb, J.G.; Herrmann, H.C.; Kodali, S.; Nombela-Franco, L.; Tamburino, C.; Jilaihawi, H.; Masson, J.B.; de Brito, F.S., Jr; Ferreira, M.C.; Lima, V.C.; Mangione, J.A.; Iung, B.; Vahanian, A.; Durand, E.; Tuzcu, E.M.; Hayek, S.S.; Angulo-Llanos, R.; Gómez-Doblas, J.J.; Castillo, J.C.; Dvir, D.; Leon, M.B.; Garcia, E.; Cobiella, J.; Vilacosta, I.; Barbanti, M.; R Makkar, R.; Ribeiro, H.B.; Urena, M.; Dumont, E.; Pibarot, P.; Lopez, J.; San Roman, A.; Rodés-Cabau, J. Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry. Circulation, 2015, 131(18), 1566-1574.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.114.014089] [PMID: 25753535]
[28]
Dickerman, S.A.; Abrutyn, E.; Barsic, B.; Bouza, E.; Cecchi, E.; Moreno, A.; Doco-Lecompte, T.; Eisen, D.P.; Fortes, C.Q.; Fowler, V.G., Jr; Lerakis, S.; Miro, J.M.; Pappas, P.; Peterson, G.E.; Rubinstein, E.; Sexton, D.J.; Suter, F.; Tornos, P.; Verhagen, D.W.; Cabell, C.H.; Wang, A.; Woods, C.W.; Cabell, C.H. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am. Heart J., 2007, 154(6), 1086-1094.
[http://dx.doi.org/10.1016/j.ahj.2007.07.023] [PMID: 18035080]
[29]
Nihoyannopoulos, P.; Oakley, C.M.; Exadactylos, N.; Ribeiro, P.; Westaby, S.; Foale, R.A. Duration of symptoms and the effects of a more aggressive surgical policy: two factors affecting prognosis of infective endocarditis. Eur. Heart J., 1985, 6(5), 380-390.
[http://dx.doi.org/10.1093/oxfordjournals.eurheartj.a061876] [PMID: 4043095]
[30]
Li, J.S.; Sexton, D.J.; Mick, N.; Nettles, R.; Fowler, V.G., Jr; Ryan, T.; Bashore, T.; Corey, G.R. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis., 2000, 30(4), 633-638.
[http://dx.doi.org/10.1086/313753] [PMID: 10770721]
[31]
Feuchtner, G.M.; Stolzmann, P.; Dichtl, W.; Schertler, T.; Bonatti, J.; Scheffel, H.; Mueller, S.; Plass, A.; Mueller, L.; Bartel, T.; Wolf, F.; Alkadhi, H. Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings. J. Am. Coll. Cardiol., 2009, 53(5), 436-444.
[http://dx.doi.org/10.1016/j.jacc.2008.01.077] [PMID: 19179202]
[32]
Habib, G.; Lancellotti, P.; Antunes, M.J.; Bongiorni, M.G.; Casalta, J.P.; Del Zotti, F.; Dulgheru, R.; El Khoury, G.; Erba, P.A.; Iung, B.; Miro, J.M.; Mulder, B.J.; Plonska-Gosciniak, E.; Price, S.; Roos-Hesselink, J.; Snygg-Martin, U.; Thuny, F.; Tornos Mas, P.; Vilacosta, I.; Zamorano, J.L. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the european society of cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur. Heart J., 2015, 36(44), 3075-3128.
[http://dx.doi.org/10.1093/eurheartj/ehv319] [PMID: 26320109]
[33]
Baddour, L.M.; Wilson, W.R.; Bayer, A.S.; Fowler, V.G., Jr; Tleyjeh, I.M.; Rybak, M.J.; Barsic, B.; Lockhart, P.B.; Gewitz, M.H.; Levison, M.E.; Bolger, A.F.; Steckelberg, J.M.; Baltimore, R.S.; Fink, A.M.; O’Gara, P.; Taubert, K.A. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the american heart association. Circulation, 2015, 132(15), 1435-1486.
[http://dx.doi.org/10.1161/CIR.0000000000000296] [PMID: 26373316]
[34]
Plank, F.; Mueller, S.; Uprimny, C.; Hangler, H.; Feuchtner, G. Detection of bioprosthetic valve infection by image fusion of (18)fluorodeoxyglucose-positron emission tomography and computed tomography. Interact. Cardiovasc. Thorac. Surg., 2012, 14(3), 364-366.
[http://dx.doi.org/10.1093/icvts/ivr107] [PMID: 22180605]
[35]
Zietlow, K.; Bazemore, T.C.; Parikh, K.S. Diagnosing pulmonic valve infective endocarditis with positron emission tomography-CT. BMJ Case Rep., 2016, 2016bcr2015213491
[http://dx.doi.org/10.1136/bcr-2015-213491] [PMID: 26833782]
[36]
Kouijzer, I.J.E.; Vos, F.J.; Janssen, M.J.R.; van Dijk, A.P.J.; Oyen, W.J.G.; Bleeker-Rovers, C.P. The value of 18F-FDG PET/CT in diagnosing infectious endocarditis. Eur. J. Nucl. Med. Mol. Imaging, 2013, 40(7), 1102-1107.
[http://dx.doi.org/10.1007/s00259-013-2376-0] [PMID: 23471580]
[37]
Granados, U.; Fuster, D.; Pericas, J.M.; Llopis, J.L.; Ninot, S.; Quintana, E.; Almela, M.; Paré, C.; Tolosana, J.M.; Falces, C.; Moreno, A.; Pons, F.; Lomeña, F.; Miro, J.M. Diagnostic accuracy of 18F-FDG PET/CT in infective endocarditis and implantable cardiac electronic device infection: a cross-sectional study. J. Nucl. Med., 2016, 57(11), 1726-1732.
[http://dx.doi.org/10.2967/jnumed.116.173690] [PMID: 27261514]
[38]
de Camargo, R.A.; Bitencourt, M.S.; Meneghetti, J.C.; Soares, J.; Gonçalves, L.F.T.; Buchpiguel, C.A.; Paixão, M.R.; Felicio, M.F.; Soeiro, A.M.; Strabelli, T.M.V.; Mansur, A.J.; Tarasoutchi, F.; de Oliveira, M.T.; Castelli, J.B.; Gualandro, D.M.; Pocebon, L.Z.; Blankstein, R.; Alavi, A.; Moore, J.E.; Millar, B.C.; Siciliano, R.F. The role of 18F-FDG-PET/CT in the diagnosis of left-sided endocarditis: native vs. prosthetic valves endocarditis. Clin. Infect. Dis., 2020, 70(4), 583-594.
[PMID: 30949690]
[39]
Saby, L.; Laas, O.; Habib, G.; Cammilleri, S.; Mancini, J.; Tessonnier, L.; Casalta, J.P.; Gouriet, F.; Riberi, A.; Avierinos, J.F.; Collart, F.; Mundler, O.; Raoult, D.; Thuny, F. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J. Am. Coll. Cardiol., 2013, 61(23), 2374-2382.
[http://dx.doi.org/10.1016/j.jacc.2013.01.092] [PMID: 23583251]
[40]
Pizzi, M.N.; Roque, A.; Fernández-Hidalgo, N.; Cuéllar-Calabria, H.; Ferreira-González, I.; Gonzàlez-Alujas, M.T.; Oristrell, G.; Gracia-Sánchez, L.; González, J.J.; Rodríguez-Palomares, J.; Galiñanes, M.; Maisterra-Santos, O.; Garcia-Dorado, D.; Castell-Conesa, J.; Almirante, B.; Aguadé-Bruix, S.; Tornos, P. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-FDG-PET/CT-angiography: initial results at an infective endocarditis referral center. Circulation, 2015, 132, 1113-1126.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.115.015316] [PMID: 26276890]
[41]
Swart, L.E.; Gomes, A.; Scholtens, A.M.; Sinha, B.; Tanis, W.; Lam, M.G.E.H.; van der Vlugt, M.J.; Streukens, S.A.F.; Aarntzen, E.H.J.G.; Bucerius, J.; van Assen, S.; Bleeker-Rovers, C.P.; van Geel, P.P.; Krestin, G.P.; van Melle, J.P.; Roos-Hesselink, J.W.; Slart, R.H.J.A.; Glaudemans, A.W.J.M.; Budde, R.P.J. Improving the diagnostic performance of 18F-FDG PET/CT in prosthetic heart valve endocarditis. Circulation, 2018, 138, 1412-1427.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035032] [PMID: 30018167]
[42]
Bensimhon, L.; Lavergne, T.; Hugonnet, F.; Mainardi, J.L.; Latremouille, C.; Maunoury, C.; Lepillier, A.; Le Heuzey, J.Y.; Faraggi, M. Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study. Clin. Microbiol. Infect., 2011, 17(6), 836-844.
[http://dx.doi.org/10.1111/j.1469-0691.2010.03312.x] [PMID: 20636421]
[43]
Cautela, J.; Alessandrini, S.; Cammilleri, S.; Giorgi, R.; Richet, H.; Casalta, J.P.; Habib, G.; Raoult, D.; Mundler, O.; Deharo, J.C. Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: a pilot study. Europace, 2013, 15(2), 252-257.
[http://dx.doi.org/10.1093/europace/eus335] [PMID: 23148119]
[44]
Ahmed, F.Z.; James, J.; Cunnington, C.; Motwani, M.; Fullwood, C.; Hooper, J.; Burns, P.; Qamruddin, A.; Al-Bahrani, G.; Armstrong, I.; Tout, D.; Clarke, B.; Sandoe, J.A.; Arumugam, P.; Mamas, M.A.; Zaidi, A.M. Early diagnosis of cardiac implantable electronic device generator pocket infection using ¹⁸F-FDG-PET/CT. Eur. Heart J. Cardiovasc. Imaging, 2015, 16(5), 521-530.
[http://dx.doi.org/10.1093/ehjci/jeu295] [PMID: 25651856]
[45]
Leccisotti, L.; Perna, F.; Lago, M.; Leo, M.; Stefanelli, A.; Calcagni, M.L.; Pelargonio, G.; Narducci, M.L.; Bencardino, G.; Bellocci, F.; Giordano, A. Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging. J. Nucl. Cardiol., 2014, 21(3), 622-632.
[http://dx.doi.org/10.1007/s12350-014-9896-2] [PMID: 24715624]
[46]
Tlili, G.; Amraoui, S.; Mesguich, C.; Rivière, A.; Bordachar, P.; Hindié, E.; Bordenave, L. High performances of (18)F-fluorodeoxyglucose PET-CT in cardiac implantable device infections: A study of 40 patients. J. Nucl. Cardiol., 2015, 22(4), 787-798.
[http://dx.doi.org/10.1007/s12350-015-0067-x] [PMID: 25788402]
[47]
Mahmood, M.; Kendi, A.T.; Farid, S.; Ajmal, S.; Johnson, G.B.; Baddour, L.M.; Chareonthaitawee, P.; Friedman, P.A.; Sohail, M.R. Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J. Nucl. Cardiol., 2019, 26(3), 958-970.
[http://dx.doi.org/10.1007/s12350-017-1063-0] [PMID: 28913626]
[48]
Van Riet, J.; Hill, E.E.; Gheysens, O.; Dymarkowski, S.; Herregods, M.C.; Herijgers, P.; Peetermans, W.E.; Mortelmans, L. (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur. J. Nucl. Med. Mol. Imaging, 2010, 37(6), 1189-1197.
[http://dx.doi.org/10.1007/s00259-010-1380-x] [PMID: 20204357]
[49]
Özcan, C.; Asmar, A.; Gill, S.; Thomassen, A.; Diederichsen, A.C.P. The value of FDG-PET/CT in the diagnostic work-up of extra cardiac infectious manifestations in infectious endocarditis. Int. J. Cardiovasc. Imaging, 2013, 29(7), 1629-1637.
[http://dx.doi.org/10.1007/s10554-013-0241-7] [PMID: 23695724]
[50]
Kestler, M.; Muñoz, P.; Rodríguez-Créixems, M.; Rotger, A.; Jimenez-Requena, F.; Mari, A.; Orcajo, J.; Hernández, L.; Alonso, J.C.; Bouza, E. Role of (18)F-FDG PET in Patients with Infectious Endocarditis. J. Nucl. Med., 2014, 55(7), 1093-1098.
[http://dx.doi.org/10.2967/jnumed.113.134981] [PMID: 24812248]
[51]
Loureiro-Amigo, J.; Fernández-Hidalgo, N.; Pijuan-Domènech, A.; Dos-Subirà, L.; Subirana-Domènech, T.; Gonzàlez-Alujas, T.; González-López, J.J.; Tornos-Mas, P.; García-Dorado, D.; Almirante, B. [Infective endocarditis in adult patients with congenital heart disease. Experience from a reference centre]. Enferm. Infecc. Microbiol. Clin., 2016, 34(10), 626-632.
[http://dx.doi.org/10.1016/j.eimc.2016.01.004] [PMID: 26860418]
[52]
Scholtens, A.M.; Budde, R.P.J.; Lam, M.G.E.H.; Verberne, H.J. FDG PET/CT in prosthetic heart valve endocarditis: There is no need to wait. J. Nucl. Cardiol., 2017, 24(5), 1540-1541.
[http://dx.doi.org/10.1007/s12350-017-0938-4] [PMID: 28560560]
[53]
Schouten, L.R.; Verberne, H.J.; Bouma, B.J.; van Eck-Smit, B.L.; Mulder, B.J. Surgical glue for repair of the aortic root as a possible explanation for increased F-18 FDG uptake. J. Nucl. Cardiol., 2008, 15(1), 146-147.
[http://dx.doi.org/10.1016/j.nuclcard.2007.11.009] [PMID: 18242493]
[54]
Fan, C.M.; Fischman, A.J.; Kwek, B.H.; Abbara, S.; Aquino, S.L. Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET. AJR Am. J. Roentgenol., 2005, 184(1), 339-342.
[http://dx.doi.org/10.2214/ajr.184.1.01840339] [PMID: 15615998]
[55]
Rahbar, K.; Seifarth, H.; Schäfers, M.; Stegger, L.; Hoffmeier, A.; Spieker, T.; Tiemann, K.; Maintz, D.; Scheld, H.H.; Schober, O.; Weckesser, M. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J. Nucl. Med., 2012, 53(6), 856-863.
[http://dx.doi.org/10.2967/jnumed.111.095364] [PMID: 22577239]
[56]
Kaderli, A.A.; Baran, I.; Aydin, O.; Bicer, M.; Akpinar, T.; Ozkalemkas, F.; Yesilbursa, D.; Gullulu, S. Diffuse involvement of the heart and great vessels in primary cardiac lymphoma. Eur. J. Echocardiogr., 2010, 11(1), 74-76.
[http://dx.doi.org/10.1093/ejechocard/jep111] [PMID: 19759028]
[57]
García, J.R.; Simó, M.; Huguet, M.; Ysamat, M.; Lomeña, F. Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma. Clin. Transl. Oncol., 2006, 8(2), 124-128.
[http://dx.doi.org/10.1007/s12094-006-0169-7] [PMID: 16632427]
[58]
Nishimura, R.A.; Otto, C.M.; Bonow, R.O.; Carabello, B.A.; Erwin, J.P., III; Guyton, R.A.; O’Gara, P.T.; Ruiz, C.E.; Skubas, N.J.; Sorajja, P.; Sundt, T.M., III; Thomas, J.D. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol., 2014, 63(22), 2438-2488.
[http://dx.doi.org/10.1016/j.jacc.2014.02.537] [PMID: 24603192]
[59]
Botelho-Nevers, E.; Thuny, F.; Casalta, J.P.; Richet, H.; Gouriet, F.; Collart, F.; Riberi, A.; Habib, G.; Raoult, D. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch. Intern. Med., 2009, 169(14), 1290-1298.
[http://dx.doi.org/10.1001/archinternmed.2009.192] [PMID: 19636030]
[60]
Caforio, A.L.; Pankuweit, S.; Arbustini, E.; Basso, C.; Gimeno-Blanes, J.; Felix, S.B.; Fu, M.; Heliö, T.; Heymans, S.; Jahns, R.; Klingel, K.; Linhart, A.; Maisch, B.; McKenna, W.; Mogensen, J.; Pinto, Y.M.; Ristic, A.; Schultheiss, H.P.; Seggewiss, H.; Tavazzi, L.; Thiene, G.; Yilmaz, A.; Charron, P.; Elliott, P.M. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J., 2013, 34(33), 2636-2648, 2648a-2648d.
[http://dx.doi.org/10.1093/eurheartj/eht210] [PMID: 23824828]
[61]
Friedrich, M.G.; Sechtem, U.; Schulz-Menger, J.; Holmvang, G.; Alakija, P.; Cooper, L.T.; White, J.A.; Abdel-Aty, H.; Gutberlet, M.; Prasad, S.; Aletras, A.; Laissy, J.P.; Paterson, I.; Filipchuk, N.G.; Kumar, A.; Pauschinger, M.; Liu, P. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J. Am. Coll. Cardiol., 2009, 53(17), 1475-1487.
[http://dx.doi.org/10.1016/j.jacc.2009.02.007] [PMID: 19389557]
[62]
Ferreira, V.M.; Schulz-Menger, J.; Holmvang, G.; Kramer, C.M.; Carbone, I.; Sechtem, U.; Kindermann, I.; Gutberlet, M.; Cooper, L.T.; Liu, P.; Friedrich, M.G. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J. Am. Coll. Cardiol., 2018, 72(24), 3158-3176.
[http://dx.doi.org/10.1016/j.jacc.2018.09.072] [PMID: 30545455]
[63]
Aquaro, G.D.; Ghebru Habtemicael, Y.; Camastra, G.; Monti, L.; Dellegrottaglie, S.; Moro, C.; Lanzillo, C.; Scatteia, A.; Di Roma, M.; Pontone, G.; Perazzolo Marra, M.; Barison, A.; Di Bella, G. Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis. J. Am. Coll. Cardiol., 2019, 74(20), 2439-2448.
[http://dx.doi.org/10.1016/j.jacc.2019.08.1061] [PMID: 31727281]
[64]
Shields, R.C.; Tazelaar, H.D.; Berry, G.J.; Cooper, L.T., Jr The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis. J. Card. Fail., 2002, 8(2), 74-78.
[http://dx.doi.org/10.1054/jcaf.2002.32196] [PMID: 12016630]
[65]
Sekiguchi, M.; Hiroe, M.; Take, M.; Hirosawa, K. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. II. Myocarditis. Jpn. Circ. J., 1980, 44(4), 264-273.
[http://dx.doi.org/10.1253/jcj.44.264] [PMID: 6154812]
[66]
Hauck, A.J.; Kearney, D.L.; Edwards, W.D. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin. Proc., 1989, 64(10), 1235-1245.
[http://dx.doi.org/10.1016/S0025-6196(12)61286-5] [PMID: 2593714]
[67]
Tanimura, M.; Dohi, K.; Imanaka-Yoshida, K.; Omori, T.; Moriwaki, K.; Nakamori, S.; Yamada, N.; Ito, M. Fulminant myocarditis with prolonged active lymphocytic infiltration after hemodynamic recovery. Int. Heart J., 2017, 58(2), 294-297.
[http://dx.doi.org/10.1536/ihj.16-225] [PMID: 28320995]
[68]
Moriwaki, K.; Dohi, K.; Omori, T.; Tanimura, M.; Sugiura, E.; Nakamori, S.; Sawai, T.; Imanaka-Yoshida, K.; Yamada, N.; Ito, M. A survival case of fulminant right-side dominant eosinophilic myocarditis. Int. Heart J., 2017, 58(3), 459-462.
[http://dx.doi.org/10.1536/ihj.16-338] [PMID: 28496024]
[69]
Ozawa, K.; Funabashi, N.; Daimon, M.; Takaoka, H.; Takano, H.; Uehara, M.; Kobayashi, Y. Determination of optimum periods between onset of suspected acute myocarditis and ¹⁸F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium. Int. J. Cardiol., 2013, 169(3), 196-200.
[http://dx.doi.org/10.1016/j.ijcard.2013.08.098] [PMID: 24075573]
[70]
Perel-Winkler, A.; Bokhari, S.; Perez-Recio, T.; Zartoshti, A.; Askanase, A.; Geraldino-Pardilla, L. Myocarditis in systemic lupus erythematosus diagnosed by 18F-fluorodeoxyglucose positron emission tomography. Lupus Sci. Med., 2018, 5(1)e000265
[http://dx.doi.org/10.1136/lupus-2018-000265] [PMID: 30094040]
[71]
Besenyi, Z; Ágoston, G; Hemelein, R; Bakos, A; Nagy, FT; Varga, A; Kovács, L; Pávics, L Detection of myocardial inflammation by 18F-FDG-PET/CT in patients with systemic sclerosis without cardiac symptoms: a pilot study. Clin Exp Rheumatol., 2019, Suppl 119(4), 88-96.
[72]
Luetkens, J.A.; Doerner, J.; Thomas, D.K.; Dabir, D.; Gieseke, J.; Sprinkart, A.M.; Fimmers, R.; Stehning, C.; Homsi, R.; Schwab, J.O.; Schild, H.; Naehle, C.P. Acute myocarditis: multiparametric cardiac MR imaging. Radiology, 2014, 273(2), 383-392.
[http://dx.doi.org/10.1148/radiol.14132540] [PMID: 24910904]
[73]
Lurz, P.; Eitel, I.; Adam, J.; Steiner, J.; Grothoff, M.; Desch, S.; Fuernau, G.; de Waha, S.; Sareban, M.; Luecke, C.; Klingel, K.; Kandolf, R.; Schuler, G.; Gutberlet, M.; Thiele, H. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc. Imaging, 2012, 5(5), 513-524.
[http://dx.doi.org/10.1016/j.jcmg.2011.11.022] [PMID: 22595159]
[74]
Nensa, F.; Kloth, J.; Tezgah, E.; Poeppel, T.D.; Heusch, P.; Goebel, J.; Nassenstein, K.; Schlosser, T. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI. J. Nucl. Cardiol., 2018, 25(3), 785-794.
[http://dx.doi.org/10.1007/s12350-016-0616-y] [PMID: 27638745]
[75]
Rybicki, B.A.; Major, M.; Popovich, J., Jr; Maliarik, M.J.; Iannuzzi, M.C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am. J. Epidemiol., 1997, 145(3), 234-241.
[http://dx.doi.org/10.1093/oxfordjournals.aje.a009096] [PMID: 9012596]
[76]
Silverman, K.J.; Hutchins, G.M.; Bulkley, B.H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation, 1978, 58(6), 1204-1211.
[http://dx.doi.org/10.1161/01.CIR.58.6.1204] [PMID: 709777]
[77]
Yazaki, Y.; Isobe, M.; Hiroe, M.; Morimoto, S.; Hiramitsu, S.; Nakano, T.; Izumi, T.; Sekiguchi, M. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am. J. Cardiol., 2001, 88(9), 1006-1010.
[http://dx.doi.org/10.1016/S0002-9149(01)01978-6] [PMID: 11703997]
[78]
Chiu, C.Z.; Nakatani, S.; Zhang, G.; Tachibana, T.; Ohmori, F.; Yamagishi, M.; Kitakaze, M.; Tomoike, H.; Miyatake, K. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am. J. Cardiol., 2005, 95(1), 143-146.
[http://dx.doi.org/10.1016/j.amjcard.2004.08.083] [PMID: 15619415]
[79]
Bennett, M.K.; Gilotra, N.A.; Harrington, C.; Rao, S.; Dunn, J.M.; Freitag, T.B.; Halushka, M.K.; Russell, S.D. Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000-2009. Circ Heart Fail, 2013, 6(4), 676-684.
[http://dx.doi.org/10.1161/CIRCHEARTFAILURE.112.000087] [PMID: 23733916]
[80]
Birnie, D.H.; Sauer, W.H.; Bogun, F.; Cooper, J.M.; Culver, D.A.; Duvernoy, C.S.; Judson, M.A.; Kron, J.; Mehta, D.; Cosedis Nielsen, J.; Patel, A.R.; Ohe, T.; Raatikainen, P.; Soejima, K. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm, 2014, 11(7), 1305-1323.
[http://dx.doi.org/10.1016/j.hrthm.2014.03.043] [PMID: 24819193]
[81]
Youssef, G.; Leung, E.; Mylonas, I.; Nery, P.; Williams, K.; Wisenberg, G.; Gulenchyn, K.Y.; Dekemp, R.A.; Dasilva, J.; Birnie, D.; Wells, G.A.; Beanlands, R.S. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J. Nucl. Med., 2012, 53(2), 241-248.
[http://dx.doi.org/10.2967/jnumed.111.090662] [PMID: 22228794]
[82]
Vita, T.; Okada, D.R.; Veillet-Chowdhury, M.; Bravo, P.E.; Mullins, E.; Hulten, E.; Agrawal, M.; Madan, R.; Taqueti, V.R.; Steigner, M.; Skali, H.; Kwong, R.Y.; Stewart, G.C.; Dorbala, S.; Di Carli, M.F.; Blankstein, R. Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging, 2018, 11(1)e007030
[http://dx.doi.org/10.1161/CIRCIMAGING.117.007030] [PMID: 29335272]
[83]
Hanneman, K.; Kadoch, M.; Guo, H.H.; Jamali, M.; Quon, A.; Iagaru, A.; Herfkens, R. Initial experience with simultaneous 18F-FDG PET/MRI in the evaluation of cardiac sarcoidosis and myocarditis. Clin. Nucl. Med., 2017, 42(7), e328-e334.
[http://dx.doi.org/10.1097/RLU.0000000000001669] [PMID: 28418949]
[84]
Dweck, M.R.; Abgral, R.; Trivieri, M.G.; Robson, P.M.; Karakatsanis, N.; Mani, V.; Palmisano, A.; Miller, M.A.; Lala, A.; Chang, H.L.; Sanz, J.; Contreras, J.; Narula, J.; Fuster, V.; Padilla, M.; Fayad, Z.A.; Kovacic, J.C. Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis. JACC Cardiovasc. Imaging, 2018, 11(1), 94-107.
[http://dx.doi.org/10.1016/j.jcmg.2017.02.021] [PMID: 28624396]
[85]
Wicks, E.C.; Menezes, L.J.; Barnes, A.; Mohiddin, S.A.; Sekhri, N.; Porter, J.C.; Booth, H.L.; Garrett, E.; Patel, R.S.; Pavlou, M.; Groves, A.M.; Elliott, P.M. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis. Eur. Heart J. Cardiovasc. Imaging, 2018, 19(7), 757-767.
[http://dx.doi.org/10.1093/ehjci/jex340] [PMID: 29319785]
[86]
Blankstein, R.; Osborne, M.; Naya, M.; Waller, A.; Kim, C.K.; Murthy, V.L.; Kazemian, P.; Kwong, R.Y.; Tokuda, M.; Skali, H.; Padera, R.; Hainer, J.; Stevenson, W.G.; Dorbala, S.; Di Carli, M.F. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J. Am. Coll. Cardiol., 2014, 63(4), 329-336.
[http://dx.doi.org/10.1016/j.jacc.2013.09.022] [PMID: 24140661]
[87]
Flores, R.J.; Flaherty, K.R.; Jin, Z.; Bokhari, S. The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis. J. Nucl. Cardiol., 2018.
[http://dx.doi.org/10.1007/s12350-018-01504-y] [PMID: 30421379]
[88]
Matthews, R.; Bench, T.; Meng, H.; Franceschi, D.; Relan, N.; Brown, D.L. Diagnosis and monitoring of cardiac sarcoidosis with delayed-enhanced MRI and 18F-FDG PET-CT. J. Nucl. Cardiol., 2012, 19(4), 807-810.
[http://dx.doi.org/10.1007/s12350-012-9550-9] [PMID: 22466988]
[89]
Sobic-Saranovic, D.P.; Grozdic, I.T.; Videnovic-Ivanov, J.; Vucinic-Mihailovic, V.; Artiko, V.M.; Saranovic, D.Z.; Pavlovic, S.V.; Obradovic, V.B. Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis. Clin. Nucl. Med., 2013, 38(7), 516-521.
[http://dx.doi.org/10.1097/RLU.0b013e31828731f5] [PMID: 23486337]
[90]
Yamagishi, H.; Shirai, N.; Takagi, M.; Yoshiyama, M.; Akioka, K.; Takeuchi, K.; Yoshikawa, J. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J. Nucl. Med., 2003, 44(7), 1030-1036.
[PMID: 12843216]
[91]
Chareonthaitawee, P.; Beanlands, R.S.; Chen, W.; Dorbala, S.; Miller, E.J.; Murthy, V.L.; Birnie, D.H.; Chen, E.S.; Cooper, L.T.; Tung, R.H.; White, E.S.; Borges-Neto, S.; Di Carli, M.F.; Gropler, R.J.; Ruddy, T.D.; Schindler, T.H.; Blankstein, R. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J. Nucl. Med., 2017, 58(8), 1341-1353.
[http://dx.doi.org/10.2967/jnumed.117.196287] [PMID: 28765228]
[92]
Nensa, F.; Bamberg, F.; Rischpler, C.; Menezes, L.; Poeppel, T.D.; la Fougère, C.; Beitzke, D.; Rasul, S.; Loewe, C.; Nikolaou, K.; Bucerius, J.; Kjaer, A.; Gutberlet, M.; Prakken, N.H.; Vliegenthart, R.; Slart, R.H.J.A.; Nekolla, S.G.; Lassen, M.L.; Pichler, B.J.; Schlosser, T.; Jacquier, A.; Quick, H.H.; Schäfers, M.; Hacker, M. Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM). Eur. Radiol., 2018, 28(10), 4086-4101.
[http://dx.doi.org/10.1007/s00330-017-5008-4] [PMID: 29717368]
[93]
Imazio, M.; Cecchi, E.; Demichelis, B.; Chinaglia, A.; Ierna, S.; Demarie, D.; Ghisio, A.; Pomari, F.; Belli, R.; Trinchero, R. Myopericarditis versus viral or idiopathic acute pericarditis. Heart, 2008, 94(4), 498-501.
[http://dx.doi.org/10.1136/hrt.2006.104067] [PMID: 17575329]
[94]
Imazio, M.; Gaita, F.; LeWinter, M. Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA, 2015, 314(14), 1498-1506.
[http://dx.doi.org/10.1001/jama.2015.12763] [PMID: 26461998]
[95]
Aquaro, G.D.; Barison, A.; Cagnolo, A.; Todiere, G.; Lombardi, M.; Emdin, M. Role of tissue characterization by cardiac magnetic resonance in the diagnosis of constrictive pericarditis. Int. J. Cardiovasc. Imaging, 2015, 31(5), 1021-1031.
[http://dx.doi.org/10.1007/s10554-015-0648-4] [PMID: 25827067]
[96]
Dong, A.; Dong, H.; Wang, Y.; Cheng, C.; Zuo, C.; Lu, J. (18)F-FDG PET/CT in differentiating acute tuberculous from idiopathic pericarditis: preliminary study. Clin. Nucl. Med., 2013, 38(4), e160-e165.
[http://dx.doi.org/10.1097/RLU.0b013e31827a2537] [PMID: 23429393]
[97]
Chang, S.A.; Choi, J.Y.; Kim, E.K.; Hyun, S.H.; Jang, S.Y.; Choi, J.O.; Park, S.J.; Lee, S.C.; Park, S.W.; Oh, J.K. [(18)F]Fluorodeoxyglucose PET/CT predicts response to steroid therapy in constrictive pericarditis. J. Am. Coll. Cardiol., 2017, 69(6), 750-752.
[http://dx.doi.org/10.1016/j.jacc.2016.11.059] [PMID: 28183513]
[98]
Doherty, J.U.; Kort, S.; Mehran, R.; Schoenhagen, P.; Soman, P. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate use criteria for multimodality imaging in valvular heart disease: a report of the american college of cardiology appropriate use criteria task force, American association for thoracic surgery, American heart association, American society of echocardiography, American society of nuclear cardiology, heart rhythm society, society for cardiovascular angiography and interventions, society of cardiovascular computed tomography, society for cardiovascular magnetic resonance, and society of thoracic Surgeons. J. Am. Coll. Cardiol., 2017, 70(13), 1647-1672.
[http://dx.doi.org/10.1016/j.jacc.2017.07.732] [PMID: 28870679]
[99]
Slart, R.H.J.A.; Glaudemans, A.W.J.M.; Lancellotti, P.; Hyafil, F.; Blankstein, R.; Schwartz, R.G.; Jaber, W.A.; Russell, R.; Gimelli, A.; Rouzet, F.; Hacker, M.; Gheysens, O.; Plein, S.; Miller, E.J.; Dorbala, S.; Donal, E. A joint procedural position statement on imaging in cardiac sarcoidosis: from the cardiovascular and inflammation & infection committees of the European association of nuclear medicine, the European association of cardiovascular imaging, and the American society of nuclear cardiology. J. Nucl. Cardiol., 2018, 25(1), 298-319.
[http://dx.doi.org/10.1007/s12350-017-1043-4] [PMID: 29043557]

Rights & Permissions Print Cite
Article Metrics
18
© 2024 Bentham Science Publishers | Privacy Policy